Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

1H NMR Based Metabolomics in Human Sepsis and Healthy Serum.

Jaurila H, Koivukangas V, Koskela M, Gäddnäs F, Myllymaa S, Kullaa A, Salo T, Ala-Kokko TI.

Metabolites. 2020 Feb 15;10(2). pii: E70. doi: 10.3390/metabo10020070.

PMID:
32075299
2.

Comparative analysis of thylakoid protein complexes in state transition mutants nsi and stn7: focus on PSI and LHCII.

Koskela MM, Brünje A, Ivanauskaite A, Lopez LS, Schneider D, DeTar RA, Kunz HH, Finkemeier I, Mulo P.

Photosynth Res. 2020 Jan 23. doi: 10.1007/s11120-020-00711-4. [Epub ahead of print]

PMID:
31975158
3.

Prediction of renal outcome in Henoch-Schönlein nephritis based on biopsy findings.

Koskela M, Ylinen E, Autio-Harmainen H, Tokola H, Heikkilä P, Lohi J, Jalanko H, Nuutinen M, Jahnukainen T.

Pediatr Nephrol. 2019 Dec 3. doi: 10.1007/s00467-019-04415-3. [Epub ahead of print]

PMID:
31797094
4.

Methylprednisolone or cyclosporine a in the treatment of Henoch-Schönlein nephritis: a nationwide study.

Koskela M, Jahnukainen T, Endén K, Arikoski P, Kataja J, Nuutinen M, Ylinen E.

Pediatr Nephrol. 2019 Aug;34(8):1447-1456. doi: 10.1007/s00467-019-04238-2. Epub 2019 Apr 6.

PMID:
30955086
5.

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease.

Penttinen AM, Parkkinen I, Voutilainen MH, Koskela M, Bäck S, Their A, Richie CT, Domanskyi A, Harvey BK, Tuominen RK, Nevalaita L, Saarma M, Airavaara M.

Front Neurol. 2018 Jun 20;9:457. doi: 10.3389/fneur.2018.00457. eCollection 2018.

6.

Chloroplast Acetyltransferase NSI Is Required for State Transitions in Arabidopsis thaliana.

Koskela MM, Brünje A, Ivanauskaite A, Grabsztunowicz M, Lassowskat I, Neumann U, Dinh TV, Sindlinger J, Schwarzer D, Wirtz M, Tyystjärvi E, Finkemeier I, Mulo P.

Plant Cell. 2018 Aug;30(8):1695-1709. doi: 10.1105/tpc.18.00155. Epub 2018 Jul 2.

7.

Beyond Histones: New Substrate Proteins of Lysine Deacetylases in Arabidopsis Nuclei.

Füßl M, Lassowskat I, Née G, Koskela MM, Brünje A, Tilak P, Giese J, Leister D, Mulo P, Schwarzer D, Finkemeier I.

Front Plant Sci. 2018 Apr 10;9:461. doi: 10.3389/fpls.2018.00461. eCollection 2018.

8.

Towards developing a model to study alcohol drinking and craving in female mice housed in automated cages.

Koskela M, Piepponen TP, Andressoo JO, Võikar V, Airavaara M.

Behav Brain Res. 2018 Oct 15;352:116-124. doi: 10.1016/j.bbr.2018.03.027. Epub 2018 Mar 20.

PMID:
29572104
9.

Arabidopsis FNRL protein is an NADPH-dependent chloroplast oxidoreductase resembling bacterial ferredoxin-NADP+ reductases.

Koskela MM, Dahlström KM, Goñi G, Lehtimäki N, Nurmi M, Velazquez-Campoy A, Hanke G, Bölter B, Salminen TA, Medina M, Mulo P.

Physiol Plant. 2018 Feb;162(2):177-190. doi: 10.1111/ppl.12621. Epub 2017 Nov 12.

PMID:
28833218
10.

Post-translational Modifications in Regulation of Chloroplast Function: Recent Advances.

Grabsztunowicz M, Koskela MM, Mulo P.

Front Plant Sci. 2017 Feb 23;8:240. doi: 10.3389/fpls.2017.00240. eCollection 2017. Review.

11.

The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Koskela M, Ylinen E, Ukonmaanaho EM, Autio-Harmainen H, Heikkilä P, Lohi J, Jauhola O, Ronkainen J, Jahnukainen T, Nuutinen M.

Pediatr Nephrol. 2017 Jul;32(7):1201-1209. doi: 10.1007/s00467-017-3608-5. Epub 2017 Feb 14.

PMID:
28197887
12.

Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study.

Jaurila H, Koivukangas V, Koskela M, Gäddnäs F, Salo S, Korvala J, Risteli M, Karhu T, Herzig KH, Salo T, Ala-Kokko TI.

J Transl Med. 2017 Jan 13;15(1):11. doi: 10.1186/s12967-016-1110-7.

13.

Blister fluid and serum cytokine levels in severe sepsis in humans reflect skin dysfunction.

Koskela M, Ala-Kokko TI, Gäddnäs F, Herzig KH, Karhu T, Oikarinen A, Koivukangas V.

Acta Anaesthesiol Scand. 2017 Jan;61(1):53-61. doi: 10.1111/aas.12771. Epub 2016 Aug 11.

PMID:
27514616
14.

Update of neurotrophic factors in neurobiology of addiction and future directions.

Koskela M, Bäck S, Võikar V, Richie CT, Domanskyi A, Harvey BK, Airavaara M.

Neurobiol Dis. 2017 Jan;97(Pt B):189-200. doi: 10.1016/j.nbd.2016.05.010. Epub 2016 May 14. Review.

15.

[Update on current care guidelines. Current care guideline: Acute lower respiratory tract infection in adults].

Honkanen P, Broas M, Hedman J, Jartti A, Järvinen A, Koskela M, Meinander T, Puolijoki H, Rautakorpi U, Syrjälä H; Tiivistelmä.

Duodecim. 2015;131(5):495-6. Finnish.

PMID:
26237912
16.

The extreme Albino3 (Alb3) C terminus is required for Alb3 stability and function in Arabidopsis thaliana.

Urbischek M, Nick von Braun S, Brylok T, Gügel IL, Richter A, Koskela M, Grimm B, Mulo P, Bölter B, Soll J, Ankele E, Schwenkert S.

Planta. 2015 Sep;242(3):733-46. doi: 10.1007/s00425-015-2352-y. Epub 2015 Jun 24.

PMID:
26105652
17.

Dermal expression of laminin-332 and type IV collagen in humans with severe sepsis.

Koskela M, Gäddnäs F, Koivukangas V, Oikarinen A, Laurila J, Kallioinen M, Ala-Kokko TI.

Acta Anaesthesiol Scand. 2015 Sep;59(8):1009-14. doi: 10.1111/aas.12539. Epub 2015 Jun 1.

PMID:
26032240
18.

Posttranslational Modifications of Chloroplast Proteins: An Emerging Field.

Lehtimäki N, Koskela MM, Mulo P.

Plant Physiol. 2015 Jul;168(3):768-75. doi: 10.1104/pp.15.00117. Epub 2015 Apr 24. Review.

19.

Posttranslational modifications of FERREDOXIN-NADP+ OXIDOREDUCTASE in Arabidopsis chloroplasts.

Lehtimäki N, Koskela MM, Dahlström KM, Pakula E, Lintala M, Scholz M, Hippler M, Hanke GT, Rokka A, Battchikova N, Salminen TA, Mulo P.

Plant Physiol. 2014 Dec;166(4):1764-76. doi: 10.1104/pp.114.249094. Epub 2014 Oct 9.

20.

The role of microbes in the pathogenesis of acute rhinosinusitis in young adults.

Autio TJ, Tapiainen T, Koskenkorva T, Närkiö M, Lappalainen M, Nikkari S, Hemmilä H, Koskela KA, Koskela M, Koivunen P, Alho OP.

Laryngoscope. 2015 Jan;125(1):E1-7. doi: 10.1002/lary.24862. Epub 2014 Aug 5.

PMID:
25093843
21.

Short-term outcomes of tonsillectomy in adult patients with recurrent pharyngitis: a randomized controlled trial.

Koskenkorva T, Koivunen P, Koskela M, Niemela O, Kristo A, Alho OP.

CMAJ. 2013 May 14;185(8):E331-6. doi: 10.1503/cmaj.121852. Epub 2013 Apr 2.

22.

Molecular typing of vancomycin-resistant Enterococcus faecium with an automated repetitive sequence-based PCR microbial typing system compared with pulsed-field gel electrophoresis and multilocus sequence typing.

Kardén-Lilja M, Vuopio J, Koskela M, Tissari P, Salmenlinna S.

Scand J Infect Dis. 2013 May;45(5):350-6. doi: 10.3109/00365548.2012.737475. Epub 2012 Nov 20.

PMID:
23163892
23.

Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.

Ylisiurua P, Koskela M, Vainio O, Tuokko H.

Scand J Infect Dis. 2013 Jan;45(1):19-25. doi: 10.3109/00365548.2012.708780. Epub 2012 Sep 21.

PMID:
22998479
24.

Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment.

Ylipalosaari P, Ala-Kokko TI, Karhu J, Koskela M, Laurila J, Ohtonen P, Syrjälä H.

Crit Care. 2012 Dec 12;16(2):R62. doi: 10.1186/cc11307.

25.

True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.

Rahkonen M, Luttinen S, Koskela M, Hautala T.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2639-44. Epub 2012 Mar 31.

PMID:
22466934
26.

Intestinal bacterial translocation and tight junction structure in acute porcine pancreatitis.

Meriläinen S, Mäkelä J, Koivukangas V, Jensen HA, Rimpiläinen E, Yannopoulos F, Mäkelä T, Alestalo K, Vakkala M, Koskenkari J, Ohtonen P, Koskela M, Lehenkari P, Karttunen T, Juvonen T.

Hepatogastroenterology. 2012 Mar-Apr;59(114):599-606. doi: 10.5754/hge11157.

PMID:
22353529
27.

Looking for the Last Universal Common Ancestor (LUCA).

Koskela M, Annila A.

Genes (Basel). 2012 Jan 9;3(1):81-7. doi: 10.3390/genes3010081.

28.

Skin collagen synthesis is depressed in patients with severe sepsis.

Gäddnäs FP, Koskela M, Koivukangas V, Laurila J, Saarnio J, Risteli J, Oikarinen A, Ala-Kokko T.

Anesth Analg. 2010 Jul;111(1):156-63. doi: 10.1213/ANE.0b013e3181e1db48. Epub 2010 May 19.

PMID:
20484539
29.

Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.

Gäddnäs FP, Sutinen MM, Koskela M, Tervahartiala T, Sorsa T, Salo TA, Laurila JJ, Koivukangas V, Ala-Kokko TI, Oikarinen A.

Crit Care. 2010;14(2):R49. doi: 10.1186/cc8938. Epub 2010 Mar 31.

30.

Patient-reported complications associated with Campylobacter jejuni infection.

Schönberg-Norio D, Mattila L, Lauhio A, Katila ML, Kaukoranta SS, Koskela M, Pajarre S, Uksila J, Eerola E, Sarna S, Rautelin H.

Epidemiol Infect. 2010 Jul;138(7):1004-11. doi: 10.1017/S0950268809991099. Epub 2009 Nov 4.

PMID:
19887016
31.

Deep, respiratory tract and ear infections caused by Pseudallescheria (Scedosporium) and Microascus (Scopulariopsis) in Finland. A 10-year retrospective multi-center study.

Issakainen J, Salonen JH, Anttila VJ, Koukila-Kähkölä P, Castrén M, Liimatainen O, Vuento R, Ojanen T, Koivula I, Koskela M, Meurman O.

Med Mycol. 2010 May;48(3):458-65. doi: 10.1080/13693780903161208.

PMID:
19672782
32.

Epidermal wound healing in severe sepsis and septic shock in humans.

Koskela M, Gäddnäs F, Ala-Kokko TI, Laurila JJ, Saarnio J, Oikarinen A, Koivukangas V.

Crit Care. 2009;13(3):R100. doi: 10.1186/cc7932. Epub 2009 Jun 24.

33.

Biofilm formation by Escherichia coli isolated from patients with urinary tract infections.

Salo J, Sevander JJ, Tapiainen T, Ikäheimo I, Pokka T, Koskela M, Uhari M.

Clin Nephrol. 2009 May;71(5):501-7.

PMID:
19473609
34.

Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients.

Gäddnäs F, Koskela M, Koivukangas V, Risteli J, Oikarinen A, Laurila J, Saarnio J, Ala-Kokko T.

Crit Care. 2009;13(2):R53. doi: 10.1186/cc7780. Epub 2009 Apr 9.

35.

Clinical Candida krusei isolates remain susceptible during extensive exposure to antifungal drugs.

Hautala T, Kakko S, Siitonen T, Säily M, Koistinen P, Koskela M.

Med Mycol. 2010 Feb;48(1):79-84. doi: 10.3109/13693780902725276.

PMID:
19194820
36.

Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance.

Hautala N, Koskela M, Hautala T.

Curr Eye Res. 2008 Nov;33(11):907-11. doi: 10.1080/02713680802475338.

PMID:
19085372
37.

Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia.

Kinnunen U, Koistinen P, Ohtonen P, Koskela M, Syrjälä H.

Scand J Infect Dis. 2008;40(8):642-7. doi: 10.1080/00365540801947338.

PMID:
18979602
38.

Blood culture Gram stain and simple clinical categorisation can be used to identify patients at risk for delay in appropriate antibiotic treatment.

Veijola S, Burtonwood M, Stapf J, Kauma H, Kauppila J, Koskela M, Hautala T.

Int J Antimicrob Agents. 2008 Dec;32(6):546-7. doi: 10.1016/j.ijantimicag.2008.07.007. Epub 2008 Sep 13. No abstract available.

PMID:
18789847
39.

Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system.

Kinnunen U, Syrjälä H, Koistinen P, Koskela M.

Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):301-3. doi: 10.1007/s10096-008-0613-4. Epub 2008 Sep 2.

PMID:
18763001
40.

PicSOM-self-organizing image retrieval with MPEG-7 content descriptors.

Laaksonen J, Koskela M, Oja E.

IEEE Trans Neural Netw. 2002;13(4):841-53. doi: 10.1109/TNN.2002.1021885.

PMID:
18244480
41.

A cluster of Candida krusei infections in a haematological unit.

Hautala T, Ikäheimo I, Husu H, Säily M, Siitonen T, Koistinen P, Vuopio-Varkila J, Koskela M, Kujala P.

BMC Infect Dis. 2007 Aug 22;7:97.

42.

Occurrence of Scopulariopsis and Scedosporium in nails and keratinous skin. A 5-year retrospective multi-center study.

Issakainen J, Heikkilä H, Vainio E, Koukila-Kähkölä P, Castren M, Liimatainen O, Ojanen T, Koskela M, Meurman O.

Med Mycol. 2007 May;45(3):201-9.

PMID:
17464841
43.

Diagnostics of fungal infections in the Nordic countries: we still need to improve!

Arendrup MC, Chryssanthou E, Gaustad P, Koskela M, Sandven P, Fernandez V.

Scand J Infect Dis. 2007;39(4):337-43.

PMID:
17454898
44.

Tonsillectomy versus watchful waiting in recurrent streptococcal pharyngitis in adults: randomised controlled trial.

Alho OP, Koivunen P, Penna T, Teppo H, Koskela M, Luotonen J.

BMJ. 2007 May 5;334(7600):939. Epub 2007 Mar 8.

45.

Self-reinforced ciprofloxacin-releasing polylactide-co-glycolide 80/20 inhibits attachment and biofilm formation by Staphylococcus epidermidis: an in vitro study.

Niemelä SM, Länsman S, Ikäheimo I, Koskela M, Veiranto M, Suokas E, Törmälä P, Syrjälä H, Ashammakhi N.

J Craniofac Surg. 2006 Sep;17(5):950-6.

PMID:
17003625
46.

Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.

Schönberg-Norio D, Hänninen ML, Katila ML, Kaukoranta SS, Koskela M, Eerola E, Uksila J, Pajarre S, Rautelin H.

Antimicrob Agents Chemother. 2006 Mar;50(3):1086-8.

47.

Territorial waters of the Baltic Sea as a source of infections caused by Vibrio cholerae non-O1, non-O139: report of 3 hospitalized cases.

Lukinmaa S, Mattila K, Lehtinen V, Hakkinen M, Koskela M, Siitonen A.

Diagn Microbiol Infect Dis. 2006 Jan;54(1):1-6.

PMID:
16368474
48.

Ciprofloxacin-releasing bioabsorbable polymer is superior to titanium in preventing Staphylococcus epidermidis attachment and biofilm formation in vitro.

Niemelä SM, Ikäheimo I, Koskela M, Veiranto M, Suokas E, Törmälä P, Waris T, Ashammakhi N, Syrjälä H.

J Biomed Mater Res B Appl Biomater. 2006 Jan;76(1):8-14.

PMID:
16265660
49.

A large outbreak of campylobacteriosis associated with a municipal water supply in Finland.

Kuusi M, Nuorti JP, Hänninen ML, Koskela M, Jussila V, Kela E, Miettinen I, Ruutu P.

Epidemiol Infect. 2005 Aug;133(4):593-601.

50.

Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection.

Hautala T, Syrjälä H, Lehtinen V, Kauma H, Kauppila J, Kujala P, Pietarinen I, Ylipalosaari P, Koskela M.

Int J Antimicrob Agents. 2005 Apr;25(4):329-33.

PMID:
15784313

Supplemental Content

Loading ...
Support Center